RVTY Q1 2026 Earnings EPS Beat Drives Positive Stock Movement BRKR Q1 2026 Earnings EPS Surges Past Estimates by Over 30 FCRX Q1 2026 Earnings Slight EPS Miss Reflects Steady Performance Amid Stable Market Conditions Instil Bio Q1 2026 Earnings EPS Miss Reflects Ongoing RD Investment Day One Biopharmaceuticals Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline Cadeler AS CDLR Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Inches Higher